Inaktiver Wert

YM BioSciences Inc. Aktie

Aktien

Dauer

Zeitraum

Stil

YM Biosciences : Raises US$80.5 Million from Public Offering	29.02.12
YM Biosciences : Prices $70 Million Public Offering of Common Shares	24.02.12
YM Biosciences : Announces Proposed Public Offering of Common Shares	23.02.12
YM Biosciences : Reports Operational and Financial Results for the Second Quarter of Fiscal 2012	09.02.12
YM Biosciences : Reports Updated Phase I/II Data for its JAK1/JAK2 Inhibitor CYT387 at ASH 2011	12.12.11

Sektor

	% 1. Jan.	Kap.
IQVIA HOLDINGS INC.	+0,17 %	42,86 Mrd.
MODERNA, INC.	+10,92 %	42,74 Mrd.
LONZA GROUP AG	+44,30 %	41,36 Mrd.
CELLTRION, INC.	-6,20 %	27,68 Mrd.
ICON PUBLIC LIMITED COMPANY	+5,23 %	25,15 Mrd.
ALNYLAM PHARMACEUTICALS, INC.	-24,79 %	18,63 Mrd.
MEDPACE HOLDINGS, INC.	+26,69 %	12,37 Mrd.
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-3,13 %	11,92 Mrd.
UNITED THERAPEUTICS CORPORATION	+6,57 %	11,21 Mrd.